Craniosynostosis (CS), characterized by the premature fusion of cranial sutures, often results from aberrant activation of <i>Fibroblast growth factor receptor 2 (FGFR2)</i>, a major regulator of osteogenic differentiation in cranial mesenchyme. Here, FGFR2 is linked to craniosynostosis.